News Related to AXIS Capital

Related coverage linked through entity extraction aliases.

Novartis India Surges 20% on Stake Sale; Parent Company Shares Show Strong Momentum

Feb 20, 2026

Novartis India shares hit upper circuit after Swiss parent agreed to sell 70.68% stake to ChrysCapital-led consortium for Rs 1,445.89 crore. Meanwhile, Novartis AG shares have returned 35.5% over one year, trading at CHF126.46.

Novartis AG Sells 70.68% Stake in India Unit to ChrysCapital for Rs 1,446 Crore

Feb 20, 2026

Swiss pharmaceutical major Novartis AG has signed a definitive agreement to sell its entire 70.68% stake in Novartis India to a ChrysCapital-led consortium for Rs 1,446 crore, with a mandatory open offer for an additional 26% from public shareholders.